ArticleAnalytical chemistry2026
Top-Down versus Bottom-Up Proteomics in Highly Sensitive LC-MS-Based Profiling of Limited Samples.
Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The advantages of top-down proteomics (TDP) in the characterization of proteoforms, resulting from genetic variations, alternative splicing, and post-translational modifications (PTMs), have been well documented. However, TDP applications on limited samples have been less explored, and no direct comparison with the bottom-up proteomics (BUP) approach for the same scarce amounts of samples has been conducted to date. In this work, we processed ∼100-1000 HeLa cells using bottom-up and top-down workflows and subjected sample volumes equivalent to ∼25 and up to ∼250 HeLa cells to liquid chromatography-mass spectrometry (LC-MS)-based TDP and BUP analyses. Porous layer open-tubular (PLOT) columns were used for the separation of intact proteins in TDP MS, while traditional bead-packed columns were used for the BUP workflow. Up to 500 proteoforms and nearly 1300 proteins from cell lysates equivalent to ∼25 HeLa cells were identified in TDP and BUP, respectively. Interestingly, among all the unambiguously identified proteins from both ∼25 HeLa and ∼250 HeLa cell lysates in TDP, ∼20-30% were not identified in BUP under the same sample loading, suggesting significant complementarity between TDP and BUP approaches. Additionally, biologically relevant PTMs (e.g., acetylation, phosphorylation, and methylation) were reliably characterized in TDP as different proteoforms. We anticipate that TDP, enhanced by ultralow-flow PLOT chromatography columns coupled to MS, could be a supplementary or an alternative approach for limited-sample analysis, as it eliminates the need for protein digestion and minimizes sample cleanup, enabling rapid sample preparation while preserving proteoform information.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.